drugset / Trial / NCT04739774
Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast)
Non-randomizedCrossoverOpen-labelOther
Summary
The objective of this proposed study is to investigate the pharmacokinetics interaction between CHF6001 as substrate and Itraconazole as inhibitor of CYP3A4/5 in a drug-drug interaction study.
Timeline
- Start
- 2021-02-22
- Primary completion
- 2021-04-20
- Completion
- 2021-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | TRANIMILAST | Small molecule | — | — |